Previous reports have shown that 70% of ALL patients with damaging germline ETV6 variants exhibit hyperdiploid karyotypes with characteristic recurrent mutations in NRAS, KRAS, and PTPN11 [38]. This evidence concerns the gene KRAS and acute lymphoblastic leukemia.